Skip to main content
. 2018 Jul 25;9:1651. doi: 10.3389/fmicb.2018.01651

Table 3.

Clinical attributes of rapid, slow, and very slow progressors who were defined based on the progression pattern after the onset of HAM/TSP.

Group R
Rapid progressor (n = 66, 15.5%)
Group SSlow progressor (n = 338, 79.5%) Group VS
Very slow progressor (n = 21, 4.9%)
p-value Statistical methods Groups with significant difference
Sex: Female 51 (77.3%) 255 (75.4%) 13 (61.9%) N.S. (a)
Age at onset 55.9 ± 11.7 43.0 ± 14.0 32.4 ± 14.5 <0.001 (b) R > S > VS
Age at diagnosis 58.7 ± 11.0 51.1 ± 12.9 51.0 ± 13.5 <0.001 (b) R > S, R > VS
Age (at present∗∗) 65.6 ± 9.2 61.2 ± 10.6 62.1 ± 10.4 0.008 (b) R > S
Diagnosis delay (time from onset to diagnosis) 2.7 ± 4.3 8.1 ± 8.2 18.6 ± 12.9 <0.001 (b) R > S > VS
Disease duration (time from onset to present) 9.6 ± 7.7 18.2 ± 10.8 29.8 ± 10.0 <0.001 (b) R > S > VS
Initial symptoms (inclusive)
Gait disturbance 58 (87.9%) 277 (82.0%) 18 (85.7%) N.S. (a)
Urinary disturbance 21 (31.8%) 145 (42.9%) 7 (33.3%) N.S. (a)
Sensory disturbance (in legs) 10 (15.2%) 52 (15.4%) 2 (9.5%) N.S. (a)
Others 17 (25.8%) 99 (29.3%) 7 (33.3%) N.S. (a)
OMDS (range: 0−13) 6.6 ± 2.3 5.6 ± 2.2 5.4 ± 1.5 0.003 (b) R > S, R > VS
HAQ-DI (range: 0−3) 1.4 ± 0.6 1.1 ± 0.7 1.0 ± 0.5 0.001 (b) R > S, R > VS
Family history of HAM/TSP: Yes 2 (3.0%) 36 (10.7%) 3 (14.3%) N.S. (a)
Family history of ATL: Yes 2 (3.0%) 20 (5.9%) 1 (4.8%) N.S. (a)
History of blood transfusion
Yes (anytime) 19 (28.8%) 61 (18.0%) 2 (9.5%) N.S. (a)
Yes, before 1986 16 (24.2%) 51 (15.1%) 2 (9.5%) N.S. (a)

Statistical methods: (a) By Fisher’s exact test, (b) by analysis of variance and Tukey post hoc tests.

*Data are expressed as mean ± SD, **present is defined as the time of the subject’s initial “HAM-net” interview.

Family history of HAM/TSP indicates the subject has a first- or second-degree relative with HAM/TSP.

Family history of adult T-cell leukemia/lymphoma (ATL) indicates the subject has a first- or second degree relative with ATL.

N.S., not significant; OMDS, Osame motor disability score; HAQ-DI, health assessment questionnaire-disability index.